Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wesson Ashford

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Journal of Alzheimer'S Disease : JAD|September 13, 2002
ApoE4: is it the absence of good or the presence of bad?J Wesson Ashford
Journal of Alzheimer'S Disease : JAD|November 11, 2008
Integration of EEG and brain imaging: advancing the understanding of neuro-cognitive dysfunctionJ Wesson Ashford
Neurology|April 2, 2020
Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseaseJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|March 1, 2019
The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and TauJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|January 27, 2025
The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's diseaseJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future DirectionsJ. Wesson Ashford
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 22, 2023
Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and DepressionJ Wesson Ashford
Journal of Molecular Neuroscience : MN|June 8, 2004
APOE genotype effects on Alzheimer's disease onset and epidemiologyJ Wesson Ashford
Aging Medicine (Milton (N.S.W))|January 17, 2020
Advances in screening instruments for Alzheimer's diseaseXianbo Zhou, J Wesson Ashford
JAMA|March 13, 2008
Primary care screening for dementia and mild cognitive impairmentJ Wesson Ashford, Soo Borson
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Journal of Alzheimer'S Disease : JAD|September 13, 2002
ApoE4: is it the absence of good or the presence of bad?J Wesson Ashford
Journal of Alzheimer'S Disease : JAD|November 11, 2008
Integration of EEG and brain imaging: advancing the understanding of neuro-cognitive dysfunctionJ Wesson Ashford
Neurology|April 2, 2020
Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer diseaseJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|March 1, 2019
The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and TauJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|January 27, 2025
The VA Million Veteran Program, Alzheimer's disease, and genetics: Important steps forward but many steps still to go on the march to control dementia and Alzheimer's diseaseJ Wesson Ashford
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Treatment of Alzheimer's Disease: The Legacy of the Cholinergic Hypothesis, Neuroplasticity, and Future DirectionsJ. Wesson Ashford
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 22, 2023
Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and DepressionJ Wesson Ashford
Journal of Molecular Neuroscience : MN|June 8, 2004
APOE genotype effects on Alzheimer's disease onset and epidemiologyJ Wesson Ashford
Aging Medicine (Milton (N.S.W))|January 17, 2020
Advances in screening instruments for Alzheimer's diseaseXianbo Zhou, J Wesson Ashford
JAMA|March 13, 2008
Primary care screening for dementia and mild cognitive impairmentJ Wesson Ashford, Soo Borson
Pageof 11